Survival in progressive supranuclear palsy and frontotemporal dementia
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare survival and to identify prognostic predictors for progressive supranuclear palsy and frontotemporal dementia. BACKGROUND: Progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD) are related disorders. Homozygosity for H1 haplotype is associated with PSP, whereas several MAPT mutations have been identified in FTLD-tau. Survival duration probably reflects underlying pathophysiology or disease. METHODS: Patients with PSP and FTD were recruited by nationwide referral. Survival of 354 FTD patients was compared with that of 197 PSP patients. Cox regression analysis was performed to identify prognostic predictors. FTLD-tau was defined as Pick disease and FTDP-17 with MAPT mutations. Semiquantitative evaluation of tau-positive pathology was performed on all pathologically proven cases. RESULTS: The median survival of PSP patients (8.0 years; 95% CI 7.3 to 8.7) was significantly shorter than that of FTD patients (9.9 years; 95% CI 9.2 to 10.6). Corrected for demographic differences, PSP patients were still significantly more at risk of dying than FTD patients. In PSP, male gender, older onset-age and higher PSP Rating Scale score were identified as independent predictors for shorter survival, whereas in FTD a positive family history and an older onset-age were associated with a poor prognosis. The difference in hazard rate was even more pronounced when comparing pathologically proven cases of PSP with FTLD-tau. CONCLUSION: Survival of PSP patients is shorter than that of FTD patients, and probably reflects a more aggressive disease process in PSP. Independent predictors of shorter survival in PSP were male gender, older onset-age and higher PSP rating scale score, whereas in FTD a positive family history and higher onset-age were predictors for worse prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781 · cited 5×
“Our findings are very similar to the observations made by Hu et al,14 which showed that three-repeat FTLD-s have a longer survival than four-repeat FTLD-s and four-repeat controls, comprising PSP and CBD patients, and supports the idea that FTLD-s patients tend to have a more indolent disease course than PSP.”
BackgroundInfluentialThe evolution and pathology of frontotemporal dementia
Kertesz, A., McMonagle, P., Blair, M., Davidson, W., & Munoz, D. G. (2005) · Brain · doi:10.1093/brain/awh598 · Cited by 609
Boeve, B. F. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf454 · Cited by 73 · cited 1×
“and shows clinical, pathological and genetic overlap with frontotemporal dementia (FTD).”
Background
Cited by
Estimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population
Knopman, D. S., & Roberts, R. O. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9538-y · Cited by 236
“Rochester MN (Josephs et al. 2005) Pathologically confirmed 45 57.3+11.1 (onset) – 6.6 Philadelphia (Xie et al. 2008) Pathologically confirmed 71 61+9.5 (onset) 1+1 6.6+0.5 Netherlands (Chiu et al. 2010) Clinical diagnoses 354 57.5+8.9 – 9.9+0.7 a Cases of “bvFTD phenocopy were excluded” (Davies et al. 2006).”
InfluentialCore features of frontotemporal dementia recapitulated in progranulin knockout mice
Ghoshal, N., Dearborn, J. T., Wozniak, D. F., & Cairns, N. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.029 · Cited by 127
Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration
Lansdall, C. J., Coyle-Gilchrist, I. T. S., Vázquez Rodríguez, P., Wilcox, A., Wehmann, E., Robbins, T. W., & Rowe, J. B. (2019) · Neurology · doi:10.1212/wnl.0000000000007249 · Cited by 66
Predicting functional decline in behavioural variant frontotemporal dementia
Josephs, K. A., Whitwell, J. L., Weigand, S. D., Senjem, M. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Jack, C. R., & Petersen, R. C. (2011) · Brain · doi:10.1093/brain/awq348 · Cited by 56
Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study
Garre-Olmo, J., Ponjoan, A., Inoriza, J. M., Blanch, J., Sánchez-Pérez, I., Cubí, R., de Eugenio, R., Turró-Garriga, O., & Vilalta-Franch, J. (2019) · Clinical Epidemiology · doi:10.2147/clep.s213228 · Cited by 26
Metadata
- Authors
- Chiu, W. Z., Kaat, L. D., Seelaar, H., Rosso, S. M., Boon, A. J., Kamphorst, W., & van Swieten, J. C.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2010-04-01
- Volume
- 81
- Issue
- 4
- Pages
- 441-445
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2166543157
- Cited by
- 102
- References
- 8
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival in progressive supranuclear palsy and frontotemporal dementia. https://app.cochat.ai/papers/10.1136/jnnp.2009.195719
- The paper
- Chiu, W. Z., Kaat, L. D., Seelaar, H., Rosso, S. M., Boon, A. J., Kamphorst, W., & van Swieten, J. C. (2010). Survival in progressive supranuclear palsy and frontotemporal dementia. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2009.195719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.